Skip to main content

Get ready for Rare Disease Day!

This is a press release from NORD, the National Organization for Rare Disorders, about Rare Disease Day. I'll write more about this later.


Countdown to Rare Disease Day
CONTACT: Mary Dunkle
mdunkle@rarediseases.org(203) 744-0100 (office)(203) 942-6443 (cell)
FOR IMMEDIATE RELEASE


Day to Focus on Rare Diseases as Public Health Issue

Danbury, CT, Feb. 25, 2009-----Millions of Americans affected by rare diseases—and millions more around the world—will observe “Rare Disease Day” this Saturday (February 28, 2009) with special events, proclamations, and online postings.
A counter has been installed on the website of the National Organization for Rare Disorders (NORD) at
www.rarediseases.org to count the days, hours, minutes, and seconds until the first-ever Rare Disease Day to be observed in the United States.
“The theme of this day is that rare diseases are an important public health issue,” said NORD President Peter L. Saltonstall. “Although each disease may affect a small number of people, when considered together these diseases affect between 25 and 30 million Americans. And people with rare diseases share certain challenges such as difficulty getting a diagnosis, lack of treatment options, and problems related to reimbursement.”


NORD is organizing the Rare Disease Day observance in the U.S. Its counterpart in Europe, the European Rare Disease Organisation (EURORDIS), first got the idea for such a day last year and, this year, asked NORD to expand the observance to the U.S. Now, several other countries, including China and Australia, have signed on, too.

In the U.S., participating organizations asked their governors to issue proclamations declaring Feb. 28th Rare Disease Day in their state. At this time, the following states (shown in green) have issued proclamations:

A rare disease is one that affects fewer than 200,000 Americans. There are nearly 7,000 such diseases affecting between 25 and 30 million people in the U.S.
On Saturday, patients and their families, researchers, medical professionals, and companies developing treatments will send messages around the world to raise awareness of rare diseases and the particular problems encountered by those affected. Several special events are planned around the country, and many videos, blogs, and patient stories will be posted online.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria